Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

By  

CANCER, Vol. 120, Iss. 15, 2014-08 ,pp. : 2325-2333

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized controlled trial comparing surgical and non‐surgical periodontal therapy: a 3‐year clinical and cost‐effectiveness analysis

By  

JOURNAL OF CLINICAL PERIODONTOLOGY, Vol. 42, Iss. 8, 2015-08 ,pp. : 748-755

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of clopidogrel in STEMI patients in the Netherlands: a model based on the CLARITY trial

By Thurston S.J.   Heeg B.   de Charro F.   van Hout B.  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 641-651

Informa Healthcare

Access to resources Recommend Favorite

The 2‐Year Cost‐Effectiveness of 3 options to Treat Lumbar Spinal Stenosis Patients

By  

PAIN PRACTICE, Vol. 15, Iss. 2, 2015-02 ,pp. : 107-116

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study

By Janssen Paul GH   Gorter Kees J   Stolk Ronald P   Rutten Guy EHM  

British Journal of General Practice, Vol. 59, Iss. 558, 2009-01 ,pp. : 43-48

Royal College of General Practitioners

Access to resources Recommend Favorite